Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16359717rdf:typepubmed:Citationlld:pubmed
pubmed-article:16359717lifeskim:mentionsumls-concept:C0006801lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C0023919lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C0042700lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C0019080lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C0205227lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:16359717lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:16359717pubmed:issue3lld:pubmed
pubmed-article:16359717pubmed:dateCreated2006-2-28lld:pubmed
pubmed-article:16359717pubmed:abstractTextEnvenoming by snakes results in severe systemic and local pathology. Intravenous administration of antivenom, prepared from IgG of venom immunised horses or sheep, is the only effective treatment of systemic envenoming. Conventional antivenoms, formulated as intact IgG, papain-cleaved (Fab) or pepsin-cleaved F(ab')2 fragments, are however ineffective against the local venom effects because of their inability to penetrate the blood/tissue barrier. We have embarked on a new research program to examine (i) whether the unusually small (15 kDa) antigen-binding fragment of camelid heavy chain IgG (V(H)H) can be exploited to neutralise the local effects of envenoming and (ii) whether a novel antivenom to treat both the systemic and local effects of envenoming can be formulated by combining anti-snake venom V(H)H and conventional F(ab')2. In this preliminary study, we demonstrate that camels and llamas respond to immunisation with Echis ocellatus venom with high antibody titres and broad antigen specificity. These encouraging immunological results were matched by the successful elimination of venom-induced haemorrhage by IgG from the venom-immunised camels and llamas. Unexpectedly, we report for the first time that camelid serum contains a non-IgG, highly potent inhibitor of venom-induced haemorrhage.lld:pubmed
pubmed-article:16359717pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16359717pubmed:languageenglld:pubmed
pubmed-article:16359717pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16359717pubmed:citationSubsetIMlld:pubmed
pubmed-article:16359717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16359717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16359717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16359717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16359717pubmed:statusMEDLINElld:pubmed
pubmed-article:16359717pubmed:monthMarlld:pubmed
pubmed-article:16359717pubmed:issn0041-0101lld:pubmed
pubmed-article:16359717pubmed:authorpubmed-author:HarrisonR ARAlld:pubmed
pubmed-article:16359717pubmed:authorpubmed-author:HarmsenMMlld:pubmed
pubmed-article:16359717pubmed:authorpubmed-author:LaingG DGDlld:pubmed
pubmed-article:16359717pubmed:authorpubmed-author:ConrathKKlld:pubmed
pubmed-article:16359717pubmed:authorpubmed-author:TheakstonR...lld:pubmed
pubmed-article:16359717pubmed:authorpubmed-author:HassonS SSSlld:pubmed
pubmed-article:16359717pubmed:issnTypePrintlld:pubmed
pubmed-article:16359717pubmed:volume47lld:pubmed
pubmed-article:16359717pubmed:ownerNLMlld:pubmed
pubmed-article:16359717pubmed:authorsCompleteYlld:pubmed
pubmed-article:16359717pubmed:pagination364-8lld:pubmed
pubmed-article:16359717pubmed:dateRevised2007-8-13lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:meshHeadingpubmed-meshheading:16359717...lld:pubmed
pubmed-article:16359717pubmed:year2006lld:pubmed
pubmed-article:16359717pubmed:articleTitleNeutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera.lld:pubmed
pubmed-article:16359717pubmed:affiliationAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK. robharr@liverpool.ac.uklld:pubmed
pubmed-article:16359717pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16359717pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16359717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16359717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16359717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16359717lld:pubmed